Log in to search using one of your social media accounts:

 

IlluminOss Medical wins de novo nod from FDA for bone stabilization system
The FDA last month granted de novo clearance to the photodynamic bone stabilization system developed by IlluminOss Medical. The IlluminOss device uses a light-curable polymer, delivered in an expandable balloon catheter, to stabilize bone fractures. In a Dec. 19 letter to the East Providence, R.I.-based company, the FDA granted de novo clearance for an indication for “skeletally mature patients in the treatment of impending and actual pathological fractures of the humerus, radius and ulna from metastatic bone disease.” The federal safety watchdog said it also concluded that the IlluminOss device is Class I...
Source: Mass Device - January 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance IlluminOss Medical Inc. Source Type: news

Cochrane seeks Knowledge Translation Co-ordinator - London, UK
Salary:£25,000 - £30,000 dependant on experienceLocation: London, UKPosition: Permanent, full timeApplication Closing Date:9 Feb 2018Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.Our work is recognised as the international go...
Source: Cochrane News and Events - January 23, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

TECHLAB Receives FDA 510(k) Clearance To Market CAMPYLOBACTER QUIK CHEK(TM) and CAMPYLOBACTER CHEK(TM) Tests
Tests Help Clinicians Diagnose Diarrhea Caused by Campylobacter Bacteria BLACKSBURG, Va., Jan. 23, 2018 -- (Healthcare Sales & Marketing Network) -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastroin... Diagnostics, Gastroenterology, Product Launch TECHLAB, CAMPYLOBACTER, QUIK CHEK (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

"Killed out of love": a frame analysis of domestic violence coverage in Hong Kong - Hern ández M.
A frame analysis was conducted on a Hong Kong newspaper to determine whether news coverage of female fatalities at the hands of their intimate partners was reported in conventional domestic violence ways or if there were culture-specific explanations. Over... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

"More closeted than gayness itself": the depiction of same-sex couple violence in newspaper media - Estes ML, Webber GR.
Same-sex intimate partner violence (IPV) lacks mainstream news media coverage. News media report on those stories that are most prominent, and these stories are often shaped and presented within a White, heterosexual, upper-class, male framework. This fram... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Promoting sustainable travel behaviour through the use of smartphone applications: a review and development of a conceptual model - Andersson A, Winslott Hiselius L, Adell E.
The negative effects of transport in terms of pollution, congestion and climate change has urged the need for higher shares of cleaner and more efficient modes of transport, especially in urban settings. While new technology can solve some of these issues,... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

The interaction of extremist propaganda and anger as predictors of violent responses - Shortland N, Nader E, Imperillo N, Ross K, Dmello J.
In this study, and with a view to extending upon existing findings on the effects of general violent media on violent cognitions, we experimentally measured the relationship between exposure to extremist propaganda and violent cognitions. Our results count... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
CAMBRIDGE, Mass., Jan. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological diseas... Biopharmaceuticals, Neurology, Personnel Disarm Therapeutics, axonal degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

Perspective-taking and empathy mitigate family-of-origin risk for electronic aggression perpetration toward dating partners: a brief report - Ramos MC, Miller KF, Moss IK, Margolin G.
Electronic dating aggression among emerging adults is prevalent and has adverse consequences, yet factors that increase or decrease the risk for perpetrating electronic aggression against a romantic partner are understudied. This investigation advances the... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Top picks for Amazon ’s new headquarters (and what markets left off the finalists list can learn from them)
Atlanta and Raleigh top the list of potential second headquarters for Amazon.com (Nasdaq: AMZN). That is according to GBH Insights, a technology marketing and research firm. GBH lists the two Southern cities followed by Washington D.C., Boston and Austin as its top picks for Amazon HQ2, according to CNBC. Amazon announced its 20 finalists for the $5 billion headquarters Thursday. Los Angel es and Denver made the list but bids from Phoenix, Tucson, San Diego, Sacramento and Salt Lake City didn’t… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 22, 2018 Category: American Health Authors: Mike Sunnucks Source Type: news

Johnson and Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM
Nearly half of vision-corrected patients has astigmatism in at least one eye,(1) and full correction can provide improved visual quality of life(2) JACKSONVILLE, Fla., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision ... Devices, Ophthalmology, Product Launch Johnson & Johnson, Johnson & Johnson Vision, ACUVUE MOIST (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
SAN FRANCISCO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Symic Bio, a biopharmaceutical company developing novel matrix-targeting biotherapeutics, today announced the appointment of Hicham Alaoui, Ph.D., as Senior Vice President of Discov... Biopharmaceuticals, Personnel Symic Bio, matrix-targeting biotherapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Hologic's Cynosure Division Launches TempSure(TM) Envi
Superior Radiofrequency Treatment Minimizes Fine Facial Lines and Wrinkles, Tightens Skin Through Soft Tissue Coagulation, and Improves the Appearance of Cellulite MARLBOROUGH, Mass., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Hologic's... Devices, Dermatology, Product Launch Hologic, TempSure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas
New monthly oral tick and flea treatment offers easy dosing, efficacy in as little as four hours, all month long GREENFIELD, Ind., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Today, Elanco Animal Health, a division of Eli Lilly and Comp... Biopharmaceuticals, FDA Elanco Animal Health, Eli Lilly, Credelio, lotilaner (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
50% Discounted Launch Price Offered SAN DIEGO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- AVACEN Medical, Inc. (AVACEN) announced that it is launching sales of its AVACEN 100, an FDA-cleared and CE marked, class II dry-heat therapy medi... Devices, Product Launch AVACEN Medical, AVACEN 100, autistic spectrum disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

A tailored web-based advice tool for skiers and snowboarders: protocol for a randomized controlled trial - Kemler E, Gouttebarge V.
BACKGROUND: Being active in sports has many positive health effects. The direct effects of engaging in regular physical activity are particularly apparent in the prevention of several chronic diseases, including cardiovascular disease, diabetes, cancer, hy... (Source: SafetyLit)
Source: SafetyLit - January 22, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Sustainable transportation attitudes and health behavior change: evaluation of a brief stage-targeted video intervention - Mundorf N, Redding CA, Paiva AL.
Promoting physical activity and sustainable transportation is essential in the face of rising health care costs, obesity rates, and other public health threats resulting from lack of physical activity. Targeted communications can encourage distinct populat... (Source: SafetyLit)
Source: SafetyLit - January 22, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
NCOUVER, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its boa... Devices, Interventional, Cardiology, Personnel Neovasc , Reducer, Tiara, transcatheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
TARRYTOWN, N.Y., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization... Biopharmaceuticals, Dermatology, Regulatory Regeneron Pharmaceuticals, Sanofi, DUPIXENT, dupilumab, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-ter... Biopharmaceuticals Titan Pharmaceuticals, Braeburn Pharmaceuticals, ProNeura, Probuphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
TOKYO and SAN DIEGO, Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Vical Incorporated (NASDAQ: VICL) announced today that ASP0113, an investigat... Biopharmaceuticals Astellas Pharma, Vical , cytomegalovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

Food giant Nestlé, maker and promoter of baby formula, will soon be marketing a probiotic supplement for breastfeeding mothers
(Natural News) A license agreement between Nestlé and Spanish biotech firm Biosearch SA will see the food giant using a breast milk probiotic strain in one of its supplements, a Nutra Ingredients article reported.  According to the report, Biosearch SA recently licensed Nestlé group subsidiary Nestec SA to take hold of the global marketing of Biosearch Life’s Lactobacillus fermentum LC40... (Source: NaturalNews.com)
Source: NaturalNews.com - January 21, 2018 Category: Consumer Health News Source Type: news

When Running Is More Than a Sport
With running in a transitional period, an apparel company ’ s advertising campaign has favored images of people who use the activity to build a community. (Source: NYT Health)
Source: NYT Health - January 21, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Running Marathon Running Advertising and Marketing Disabilities Black Girls Run Marathons With Meaning Source Type: news

Monsanto’s latest marketing ploy: Labeling GMOs as “biofortified”
(Natural News) GMOs have been getting a bad name for quite some time now, and it’s hardly surprising given the near-constant stream of evidence showing the harms caused by genetically engineered crops and the pesticides used on them. As people increasingly make an effort to avoid buying these products, Monsanto has come up with a... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2018 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: Jan. 19, 2018
[Image from unsplash.com]From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news release. The device is disposable and uses an advanced instant cold compression technology to treat hemorrhoids. 2. Centric Medical gets FDA 510(k) clearance for foot & ankle screws Centric Medical announced in a Jan. 16 news release...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiac Assist Devices Cardiovascular Food & Drug Administration (FDA) Hospital Care Neurological Orthopedics Pre-Market Approval (PMA) Regulatory/Compliance Avacen Medical BioPoly Centric Medical MedTech OrthoXel Privi Source Type: news

Audax begins recapitalization of Belmont Instruments
Private equity player Audax Group has begun its recapitalization efforts with fluid warming infusion systems provider Belmont Instruments, according to a press release from financial advisor Mirus Capital Advisors. Billerica, Mass.-based Belmont produces rapid infusion systems designed to treat critically injured patients with material blood loss, according to Audax. “Belmont is a best-in-class provider of life-sustaining fluid warming infusion systems.  We are excited to partner with management to build on Belmont’s leading position and accelerate growth by continuing its investme...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Audax Group Belmont Instrument Corp Source Type: news

This Arizona bioscience firm is going back to the public markets to raise $35M
HTG Molecular Diagnostics Inc. (Nasdaq: HTGM) plans to sell 12.1 million shares of its common stock in an effort to raise $35.1 million. Plans call for using the funds for working capital and general corporate purposes, which could include capital expenditures, research and development, sales and marketing and general and administrative expenses. HTG offers a molecular profiling platform to analyze thousands of genes at a time. T he Tucson-based bioscience company filed its initial public offering… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 19, 2018 Category: American Health Authors: Angela Gonzales Source Type: news

This Arizona bioscience firm is going back to the public markets to raise $35M
HTG Molecular Diagnostics Inc. (Nasdaq: HTGM) plans to sell 12.1 million shares of its common stock in an effort to raise $35.1 million. Plans call for using the funds for working capital and general corporate purposes, which could include capital expenditures, research and development, sales and marketing and general and administrative expenses. HTG offers a molecular profiling platform to analyze thousands of genes at a time. T he Tucson-based bioscience company filed its initial public offering… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 19, 2018 Category: Biotechnology Authors: Angela Gonzales Source Type: news

MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular disease... Biopharmaceuticals, Cardiology, Personnel MyoKardia, cardiomyopathy, mavacamten (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer
40 years of industry experience in domestic and international markets related to Quality, Manufacturing, Supply Chain, Pharmaceutical Technology and Engineering BRISTOL, Tenn., Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- UPM Pharmaceutic... Biopharmaceuticals, Personnel UPM Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

Gathering Together World-Renowned Medical Device Manufacturing Suppliers, Medtec China Helps to Propel the Medical Device Localization Process
SHANGHAI, Jan. 19, 2018 -- (Healthcare Sales & Marketing Network) -- To deliver a boost to the Medical Device Industry in China, the Chinese government has proactively launched several policies directed at medical device innovation which focus on speeding... Devices, Regulatory Medtec China (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

Agents of Change Summit
February 12-13, 2018; San Diego, CA. The Agents of Change Summit unifies and expands the community of professionals using marketing and technology to change people's health behaviors for social good. (Source: PHPartners.org)
Source: PHPartners.org - January 19, 2018 Category: International Medicine & Public Health Source Type: news

Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Results of tumor response assessments by blinded independent imaging review using both mRECIST and RECIST v1.1 criteria to be presented today at the Gastrointestinal Cancers Symposium WOODCLIFF LAKE, N.J., Jan. 19, 2018 -- (Healthcare Sales & Marketing ... Biopharmaceuticals, Oncology Eisai, REFLECT study, lenvatinib, Lenvima, hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2018 Category: Pharmaceuticals Source Type: news

How a New Test Could Solve a Costly Problem
There's a costly problem affecting orthopedic patients and hospital systems, and a European molecular diagnostics company wants to be part of the solution.  Patients who have had a prosthetic joint replacement sometimes find themselves back in the hospital in excruciating pain that could either be caused by an invasive joint infection or a mechanical issue. The surgeon can puncture the joint to collect a fluid sample and have it sent to a lab for a culture test, but that takes up to two weeks to produce a result using the current standard of care technology, Curetis CEO Oliver Schacht told MD+DI.  "...
Source: MDDI - January 19, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Orthopedics Source Type: news

Durham health care analytics company acquired by Press Ganey
Durham health care analytics company Bivarus – a UNC-Chapel Hill spinout – has been acquired by Boston-based Press Ganey, which specializes in patient experience measurement and analytics, for an undisclosed amount. The acquisition comes nearly a year after Bivarus raised $4 million for sales and marketing, continued product development a nd engineering. As of last March, Bivarus had raised roughly $7.5 million to-date from investors, including Hatteras Venture Partners, Excelerate Health Ventures,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 18, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Durham health care analytics company acquired by Press Ganey
Durham health care analytics company Bivarus – a UNC-Chapel Hill spinout – has been acquired by Boston-based Press Ganey, which specializes in patient experience measurement and analytics, for an undisclosed amount. The acquisition comes nearly a year after Bivarus raised $4 million for sales and marketing, continued product development a nd engineering. As of last March, Bivarus had raised roughly $7.5 million to-date from investors, including Hatteras Venture Partners, Excelerate Health Ventures,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

European Commission Approves Amgen And Allergan's MVASI ® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Marketing Authorization Based on Global Development Program Showing MVASI is Highly Similar to Avastin® (Bevacizumab) First Biosimilar Bevacizumab Approved in the European Union THOUSAND OAKS, Calif., Jan. 18, 2018 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced that the European Commission (EC) has granted marketing authorization for MVASI® (biosimilar bevacizumab). MVASI is the first biosimilar bevacizumab approved by the EC and is approved for the treatment of certain types of cancers, including in combination with fluoropyrimidine-based chemotherapy for metastatic ...
Source: Amgen News Release - January 18, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Flexible training options for newcomers to scholarly communications from ALPSP
If you are, or know, a new recruit to scholarly communications in 2018, then do consider our online training options providing an Introduction to Journals Publishing to bring you to speed with the nuances of this sector. For those able to get to London we have a full day course running in March but if you are further afield then our online training in May is a great option. Introduction to Journals Publishing, Full Day course, London This essential course covers all aspects of journals publishing and is perfect for those starting out in their career or moving into the sector. It covers everything from peer review to online...
Source: News from STM - January 18, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: Training & Webinars Source Type: news

Edanz partners with Aries Systems to adopt Editorial Manager Ingest Service for its Author Path product
Edanz announced today that it is partnering with Aries Systems in adopting the Editorial Manager Ingest Service for its Author Path product (www.author-path.com). The Edanz Author Path was launched in beta last April in both English and Chinese. This partnership means authors using the Author Path, will be able to submit files and metadata associated with their manuscripts to the thousands of journals using Editorial Manager with a single click. “We’re very excited about partnering with Aries,” said Bruce D. Cummings, Chief Product Officer with Edanz. “The response by users to the beta test...
Source: News from STM - January 18, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: Editorial Source Type: news

Digital media-based health intervention on the promotion of women's physical activity: a quasi-experimental study - Peyman N, Rezai-Rad M, Tehrani H, Gholian-Aval M, Vahedian-Shahroodi M, Heidarian Miri H.
This study was conducted to assess the impact of a digital media-based (multi-media, internet, and mobile phone) health intervention on promotion of w... (Source: SafetyLit)
Source: SafetyLit - January 18, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
BRIDGEWATER, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical Officer. La... Diagnostics, Oncology, Personnel Clinical Genomics, colorectal cancer, COLVERA, liquid biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

New Registry Launched to Track and Improve the Quality of Cancer Care Delivered in the U.S.
Quality Oncology Practice Initiative (QOPI®) Reporting Registry is a Joint Effort of Two Leading Oncology Societies ALEXANDRIA, Va., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- A registry that tracks the quality of medical care provid... Devices, Oncology, Product Launch ASTRO, ASCO, Quality Oncology Practice Initiative, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Smith and Nephew's Episode of Care Assurance Program (eCAP) reduces hospital readmission following total joint replacement surgery
LONDON, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces results showing a near 75% decrease in readmission rates for joint arthroplasties (TJA) conduct... Devices, Orthopaedic Smith & Nephew, Episode of Care Assurance Program, total joint arthroplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome
WARREN, N.J., Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application for clobazam Oral Soluble Fil... Biopharmaceuticals, Drug Delivery Aquestive Therapeutics, clobazam, Oral Soluble Film, Lennox-Gastaut syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial
SAN ANTONIO, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its f... Devices, Interventional Bluegrass Vascular Technologies, Surfacer System, Surfacer Inside-Out (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Lannett Names Timothy C. Crew To Board Of Directors
PHILADELPHIA, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed chief executive officer (CEO), has been added to the Lannett Company Board of... Biopharmaceuticals, Generic, Personnel Lannett Company (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2018 Category: Pharmaceuticals Source Type: news

Ashfield are shortlisted for a PM Award
Ashfield Digital & Creative, alongside our colleagues at Watermeadow Medical and our clients at Edwards Lifesciences, are thrilled to announce that we have been shortlisted for a PM Society Award in the Primary Care Campaign category for ‘Listen to the Heart’. A campaign focused on the lifesaving opportunity available to GPs through the early identification of aortic stenosis. Speaking about the collaboration, which led to this campaign, Ashfield Digital & Creative Senior Vice-President Andrew Binns said, “This entry demonstrates the impact that can be achieved when strategic insights and cre...
Source: Ashfield Healthcare News - January 18, 2018 Category: Pharmaceuticals Authors: Daniel Goodwin Tags: Ashfield Source Type: news

College branding makes beer more salient to underage students
(Association for Psychological Science) Major beer companies have rolled out marketing campaigns and products -- such as 'fan cans,' store displays, and billboard ads -- that pair beer with university colors, mascots, and logos. Research published in the January 2018 issue of Psychological Science shows that such campaigns may enhance the motivational significance of marketed beer brands, especially for students who identify strongly with their university. The researchers conclude that this effect could potentially increase underage students' alcohol consumption. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 18, 2018 Category: International Medicine & Public Health Source Type: news

Life Sciences Technology Innovator eClinical Solutions LLC Appoints...
As Market Adoption of elluminate® Clinical Data Repository and Analytics Platform Increases, Company Strengthens Leadership Team and Marketing Expertise(PRWeb January 18, 2018)Read the full story at http://www.prweb.com/releases/2018/01/prweb15101081.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 18, 2018 Category: Pharmaceuticals Source Type: news

Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
ATLANTA, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra... Biopharmaceuticals, FDA Avion Pharmaceuticals, Balcoltra, levonorgestrel, ethinyl estradiol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news